Pay in 4 interest-free payments of $6.21 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Heart health and weight-related risk Weight loss may help improve some weight-related health risks, such as blood pressure, cholesterol, and insulin resistance
Effectiveness in Weight Loss While both medications are approved for weight loss, tirzepatide has been shown in studies to provide more significant weight loss compared to semaglutide
Ac, Activated
11 New Mexicos coverage was new as of the 2022 plan year, and the updated plan includes coverage of weight-loss medications as part of medically necessary treatment of morbid obesity and obesity. 12 Starting in 2025, North Dakota's EHB benchmark began to include coverage for weight-loss drugs, including GLP-1s for the treatment of morbid obesity
